Get pumped! Scientists from Oregon Health & Science University have developed a blood test called PAC-MANN that is said to be less invasive, cheaper and more robust than traditional screening methods ...

The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the ...

The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent. Two breakthroughs are ...

The symptoms of pancreatic cancer can be nonspecific, which means identifying the disease is often a challenge.

Paired with an existing test, this could become a life-saving diagnostic tool for people with a notoriously deadly form of ...

A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

Scientists at Oregon Health and Science University (OHSU) have developed a new blood test for pancreatic cancer, one of the ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

Pancreatic cancer remains difficult to treat, and is responsible for around 8 percent of all cancer deaths.It also has one of ...

Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet ...

A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...

Pancreatic cancer is one of the more deadly forms of this malady because around 80 percent of patients will be diagnosed at Stage IV, which is after the cancer has metastasized throughout the body.